Ocular toxicity of intravitreal trovafloxacin in the pigmented rabbit

Current Eye Research

Volumn 27, Issue 6, 2003, Pages 387-393

  Ng, Eugene W M ^a   Joo, Myung Jin ^a   Eong, Kah Guan Au ^a   Green, W Richard ^a,b   O'Brien, Terrence P ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Endophthalmitis; Intravitreal injection; Toxicity; Trovafloxacin

Indexed keywords

ALATROFLOXACIN; CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; AXONAL INJURY; CONTROLLED STUDY; ENDOPHTHALMITIS; ENUCLEATION; EYE TOXICITY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MALE; MICROSCOPY; NONHUMAN; OPTIC NERVE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA INJURY; RETINA NECROSIS; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTI-INFECTIVE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROQUINOLONES; INJECTIONS; MALE; MICROBIAL SENSITIVITY TESTS; NAPHTHYRIDINES; NO-OBSERVED-ADVERSE-EFFECT LEVEL; OPHTHALMOSCOPY; OPTIC DISK; RABBITS; RETINA; VITREOUS BODY;

EID: 0347623111     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.27.6.387.18192     Document Type: Article

References (17)

1. Endophthalmitis Vitrectomy Study Group. Results of the endophthalmitis vitrectomy study: A randomized trial of immediate vitrectomy and intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113:1479-1496.
2. Endophthalmitis Vitrectomy Study Group. Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol. 1996;122:830-846.
3. Johnson MW, Doft BH, Kelsey SF, Barza M, Wilson LA, Barr CC, Wisniewski SR. The endophthalmitis vitrectomy study. Relationship between clinical presentation and microbiologic spectrum. Ophthalmology. 1997;104:261-272.
4. Mandelbaum S, Forster RK, Gelender H, Culbertson WW Late onset endophthalmitis associated with filtering blebs. Ophthalmology. 1985;92:964-972.
5. Hemady R, Zaltas M, Paton B, Foster CS, Baker AS. Bacillus-induced endophthalmitis: New series of 10 cases and review of the literature. Br J Ophthalmol. 1990;74:26-29.
6. Montanari MP, Prenna M, Mingoia M, Ripa S, Varaldo PE. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones. Chemotherapy. 1998;44:85-93.
7. Bauernfeind A. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM1155), trovafloxacin, clinafloxacin, levofloxacin, and ciprofloxacin. J Antimicrob Chemother. 1997;40:639-651.
8. Aldridge KE, Ashcraft D, Bowman KA. Comparative in vitro activities of trovafloxacin (CP 99,219) and other antimicrobials against clinically significant anaerobes. Antimicrob Agents Chemother. 1997;41:484-487.
9. Ednie LM, Jacobs MR, Applebaum PC. Comparative activities of clinafloxacin against gram-positive and -negative bacteria. Antimicrob Agents Chemother. 1998;42:1269-1273.
10. Hoogkamp-Korstanje JAA. In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin, and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections. J Antimicrob Chemother. 1997;40:427-431.
11. Campochiaro PA, Conway BP. Aminoglycoside toxicity-a survey of retinal specialists. Implications for ocular use. Arch Ophthalmol. 1991;109:946-950.
12. Stevens SX, Fouraker BD, Jensen HG. Intraocular safety of ciprofloxacin. Arch Ophthalmol. 1991;109:1737-1743.
13. Smith MA, D'Aversa G, Sable M et al. Retinal toxicity of intravitreal sparfloxacin, ofloxacin, and imipenem in a rabbit model. J Toxicol-Cut & Ocular Toxicol. 1999; 18:65-73.
14. Cunha BA, Qadri SMH, Ueno Y, Walters EA, Domenico P. Antibacterial activity of trovafloxacin against nosocomial gram-positive and gram-negative isolates. J Antimicrob Chemother. 1997;39:29-34.
15. Gürler B, Ozkul Y, Bitiren M et al. Experimental intravitreal application of trovafloxacin in rabbits. Ophthalmic Res. 2001;33:228-236.
16. Karakucuk S, Mirza E, Sumerkan B, Okten T. Intravitreal trovafloxacin against experimental Staphylococcus epidermidis endophthalmitis. Ophthalmic Res. 2000;32:126-131.
17. Bertino J Jr, Fish D. The safety profile of the fluoroquinolones. Clin Ther. 2000;22:798-817.